CORT FY 2016 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$81M+61.7% YoY

Gross Profit

$79M97.5% margin

Operating Income

$10M12.5% margin

Net Income

$8M10.0% margin

EPS (Diluted)

$0.07

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$18M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$69M

Total Liabilities

$27M

Stockholders' Equity

$41M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$50M	+61.7%
Gross Profit	$79M	$49M	+62.0%
Operating Income	$10M	-$3M	+395.6%
Net Income	$8M	-$6M	+227.0%